News | October 06, 2025
Lilly to invest $1 billion+ in new contract manufacturing in India
Investment to expand manufacturing and global medicine supply capacity
Investment to expand manufacturing and global medicine supply capacity
Commercial production is expected to begin soon
Jubilant HollisterStier is a subsidiary of Jubilant Pharma Holding
The USFDA has issued 15 observations pursuant to the completion of audit. JHSGP will submit an action plan on the observations
The US FDA in its communication mentioned it may withhold approval of any pending applications or supplements in which this facility is listed.
Successful inspection outcome strengthens company’s regulatory compliance and manufacturing standards in China
The company reported robust revenue and profit growth for FY26, supported by strong CDMO performance, improving margins, and expansion across advanced manufacturing platforms
Enterprise-scale adoption in 2026 will be driven by domain-specific AI, compliance automation, and strong digital foundations across quality, manufacturing and regulatory workflows
CPHI India from 23–25 November 2026 at Yashobhoomi (India International Convention and Expo Centre), while PMEC India from 24–26 November 2026 at India Expo Mart
The company reported consolidated total income of Rs. 161.3 crore in Q4 FY26, a strong jump from Rs. 120.3 crore in the same period last year
Subscribe To Our Newsletter & Stay Updated
